(Q31048529)

28 June 2017

1 reference

title

The cancer question: an overview of recent epidemiologic and retrospective data (English)

1 reference

28 June 2017

Henderson BE

1

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

American Journal of Obstetrics and Gynecology

28 June 2017

published in

1 reference

28 June 2017

volume

161

1 reference

28 June 2017

issue

6 Pt 2

1 reference

28 June 2017

page(s)

1859-1864

1 reference

The significance of a typical endometrial hyperplasia

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Association of Exogenous Estrogen and Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Estrogens and Endometrial Cancer in a Retirement Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Exogenous estrogen and endometrial carcinoma: Case-control and incidence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Alternative analytic methods for case-control studies of estrogens and endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Estrogen use - risk of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Endometrial cancer and estrogen use. Report of a large case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Endometrial cancer in relation to patterns of menopausal estrogen use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Risk of exogenous estrogen therapy and endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

A case-control study of cancer of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Oestrogens and obesity as risk factors for endometrial cancer in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

The epidemiology of endometrial cancer in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Survival among women with endometrial cancer: a comparison of estrogen users and nonusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Oestrogen use and survival in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Replacement estrogens and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Menopausal Estrogens and Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Menopausal oestrogens and breast cancer risk: an expanded case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Exogenous estrogen and breast cancer after bilateral oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Breast cancer and estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Menopausal estrogen use and the risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

The association of replacement estrogens with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Estrogen use and breast cancer. Interaction with body mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Replacement estrogens and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Non-contraceptive oestrogens and the risk of breast cancer in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

The risk of breast cancer after estrogen and estrogen-progestin replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

Stroke prevention and oestrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980007-9

10.1016/S0002-9378(89)80007-9

7 January 2021

Identifiers

DOI

1 reference

release_jc42jj542nawvgwz6i52m5fvky

28 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jc42jj542nawvgwz6i52m5fvky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference